Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 235 | $31,547,064 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Aug 2023 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Aug 2023 | Sale | 18,000 | 9.25 | 166,500 | D |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 18,710 | 8.7731 | 164,145 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 20,000 | 8.095 | 161,900 | I |
10 Aug 2023 17:33 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 08 Aug 2023 | Sale | 14,498 | 11.0255 | 159,848 | D |
05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 02 Jun 2023 | Sale | 17,865 | 8.93 | 159,534 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Nov 2023 | Sale | 25,000 | 6.3177 | 157,942 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 9,859 | 15.999 | 157,734 | D |
19 Sep 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2023 | Sale | 18,000 | 8.66 | 155,880 | D |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 33,073 | 4.7096 | 155,761 | D |
15 Jun 2023 19:30 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 13 Jun 2023 | Sale | 15,485 | 9.9778 | 154,506 | D |
16 Nov 2023 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Nov 2023 | Sale | 20,300 | 7.2506 | 147,187 | D |
06 Mar 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Mar 2023 | Sale | 18,500 | 7.919 | 146,502 | D |
17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2024 | Sale | 15,000 | 9.3199 | 139,798 | D |
17 Jun 2024 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2024 | Sale | 15,000 | 9.2721 | 139,082 | D |
28 Apr 2023 16:32 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2022 | Sale A | 18,500 | 7.3875 | 136,669 | D |
06 Jan 2023 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jan 2023 | Sale | 18,500 | 7.3875 | 136,669 | D |
09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Aug 2024 | Sale | 20,000 | 6.5 | 130,000 | D |
06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Sep 2024 | Sale | 20,000 | 6.14 | 122,800 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 10,327 | 11.7442 | 121,282 | I |
06 Sep 2024 16:57 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Sep 2024 | Sale | 20,000 | 6.04 | 120,800 | D |
23 Feb 2024 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 22 Feb 2024 | Sale | 8,000 | 14.895 | 119,160 | D |
17 Nov 2023 17:52 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2023 | Sale | 18,000 | 6.51 | 117,180 | D |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 09 Mar 2023 | Sale | 15,000 | 7.7747 | 116,620 | D |
18 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Oct 2023 | Sale | 18,000 | 6.3 | 113,400 | D |
11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 09 Jul 2024 | Sale | 15,000 | 7.3185 | 109,778 | D |
27 Jun 2024 19:13 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 25 Jun 2024 | Sale | 11,447 | 9.5052 | 108,806 | D |
11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Jul 2024 | Sale | 15,000 | 7.2384 | 108,576 | D |
08 Feb 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 06 Feb 2024 | Sale | 11,447 | 9.3028 | 106,489 | D |
30 May 2024 18:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 May 2024 | Sale | 11,447 | 9.1677 | 104,943 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 13 Jul 2023 | Sale | 8,275 | 12.5852 | 104,143 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 20,000 | 5.1147 | 102,294 | I |
03 Apr 2024 17:42 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 02 Apr 2024 | Sale | 11,447 | 8.8182 | 100,942 | D |
05 May 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 May 2023 | Sale | 20,000 | 4.9018 | 98,036 | I |
25 Jul 2024 18:15 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 23 Jul 2024 | Sale | 11,447 | 8.4774 | 97,041 | D |
13 Jun 2024 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jun 2024 | Sale | 11,447 | 8.4531 | 96,763 | D |
15 Aug 2024 17:24 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Aug 2024 | Sale | 15,000 | 6.3501 | 95,252 | D |
15 Aug 2024 17:24 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Aug 2024 | Sale | 15,000 | 6.3455 | 95,182 | D |
12 Sep 2024 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Sep 2024 | Sale | 15,000 | 6.3153 | 94,730 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 7,898 | 11.7969 | 93,172 | D |
12 Sep 2024 18:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Sep 2024 | Sale | 15,000 | 6.1666 | 92,499 | D |
19 Jan 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jan 2023 | Sale | 10,000 | 9.1561 | 91,561 | D |
02 May 2024 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 30 Apr 2024 | Sale | 11,447 | 7.9465 | 90,964 | D |
19 Dec 2022 17:32 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2022 | Sale | 10,000 | 8.8525 | 88,525 | D |
13 Feb 2023 16:41 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 10 Feb 2023 | Purchase | 11,000 | 7.9825 | 87,808 | I |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 Apr 2024 | Sale | 11,447 | 7.6636 | 87,725 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Apr 2023 | Sale | 13,327 | 6.4559 | 86,038 | D |
14 Dec 2023 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 12 Dec 2023 | Sale | 11,447 | 7.3987 | 84,693 | D |
02 Jan 2024 16:58 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 28 Dec 2023 | Sale | 8,000 | 10.5817 | 84,654 | D |
11 Jul 2024 16:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jul 2024 | Sale | 11,447 | 7.315 | 83,735 | D |
11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 6,303 | 13.2124 | 83,278 | D |
29 Jan 2024 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 25 Jan 2024 | Sale | 8,000 | 10.3452 | 82,762 | D |
22 Aug 2024 18:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Aug 2024 | Sale | 11,447 | 7.1226 | 81,532 | D |
15 Dec 2022 17:26 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 13 Dec 2022 | Sale | 8,885 | 8.9587 | 79,598 | D |
24 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 22 Aug 2023 | Sale | 8,885 | 8.9118 | 79,181 | D |
25 Mar 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 21 Mar 2024 | Sale | 7,390 | 10.6989 | 79,065 | D |
19 Sep 2024 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 17 Sep 2024 | Sale | 11,447 | 6.8431 | 78,333 | D |
09 Feb 2023 16:53 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 07 Feb 2023 | Sale | 8,885 | 8.8084 | 78,263 | D |
07 Sep 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Sep 2023 | Sale | 8,885 | 8.7942 | 78,136 | D |
01 Jun 2023 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 30 May 2023 | Sale | 8,885 | 8.7939 | 78,134 | D |
08 Aug 2024 17:23 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 06 Aug 2024 | Sale | 11,447 | 6.8213 | 78,083 | D |
01 Dec 2022 17:14 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 29 Nov 2022 | Sale | 8,885 | 8.7547 | 77,786 | D |
26 Jan 2023 18:04 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 24 Jan 2023 | Sale | 8,885 | 8.7077 | 77,368 | D |
30 Nov 2023 17:41 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 28 Nov 2023 | Sale | 11,447 | 6.7195 | 76,918 | D |
21 Sep 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Sep 2023 | Sale | 8,885 | 8.3599 | 74,278 | D |
09 Mar 2023 17:36 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 07 Mar 2023 | Sale | 8,885 | 8.3274 | 73,989 | D |
05 Sep 2024 17:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Sep 2024 | Sale | 11,447 | 6.2652 | 71,718 | D |
23 Feb 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Feb 2023 | Sale | 8,885 | 7.733 | 68,708 | D |
12 Jan 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 10 Jan 2023 | Sale | 8,885 | 7.6852 | 68,283 | D |
23 Mar 2023 17:07 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 21 Mar 2023 | Sale | 8,885 | 7.3994 | 65,744 | D |
29 Jun 2023 17:57 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 27 Jun 2023 | Sale | 8,885 | 7.3876 | 65,639 | D |
05 Oct 2023 18:25 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 03 Oct 2023 | Sale | 8,885 | 7.2907 | 64,778 | D |
27 Jan 2023 17:03 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 26 Jan 2023 | Sale | 8,000 | 8.0684 | 64,547 | D |
29 Dec 2022 17:39 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 27 Dec 2022 | Sale | 8,885 | 7.2451 | 64,373 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 5,059 | 12.7 | 64,249 | D |
27 Jan 2023 16:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 26 Jan 2023 | Purchase | 7,886 | 7.9896 | 63,006 | I |
27 Feb 2023 17:46 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 23 Feb 2023 | Sale | 8,000 | 7.8175 | 62,540 | D |
17 Feb 2023 17:13 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Feb 2023 | Sale | 7,486 | 8.33 | 62,358 | D |
30 Dec 2022 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Dec 2022 | Sale | 8,000 | 7.6958 | 61,566 | D |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 4,373 | 14.0461 | 61,424 | D |
13 Jul 2023 16:54 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 11 Jul 2023 | Sale | 8,885 | 6.8873 | 61,194 | D |
17 Nov 2022 18:47 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2022 | Sale | 4,941 | 11.9153 | 58,873 | D |
19 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 17 Oct 2023 | Sale | 8,885 | 6.5822 | 58,483 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,693 | 12.4131 | 58,255 | I |
06 Apr 2023 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 04 Apr 2023 | Sale | 8,885 | 6.5269 | 57,992 | D |
16 Nov 2023 18:55 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 Nov 2023 | Sale | 8,885 | 6.3197 | 56,151 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 11.21 | 56,050 | D |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 4,060 | 13.3631 | 54,254 | D |
18 Oct 2022 17:08 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 14 Oct 2022 | Sale | 5,000 | 10.6259 | 53,130 | D |
20 Apr 2023 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 18 Apr 2023 | Sale | 8,885 | 5.9347 | 52,730 | D |
15 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 14 Feb 2023 | Purchase | 6,300 | 7.946 | 50,060 | I |
29 Jul 2024 18:16 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 25 Jul 2024 | Sale | 6,000 | 8.1349 | 48,809 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 4,430 | 10.8382 | 48,013 | I |
28 Jul 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Jul 2023 | Sale | 3,627 | 13.1155 | 47,570 | D |
02 Nov 2023 19:02 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 31 Oct 2023 | Sale | 8,885 | 5.2745 | 46,864 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 4,000 | 11.5648 | 46,259 | I |
03 Sep 2024 16:48 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 29 Aug 2024 | Sale | 6,000 | 7.5627 | 45,376 | D |
17 May 2023 18:22 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 May 2023 | Sale | 8,885 | 5.0918 | 45,241 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,157 | 14.0821 | 44,457 | D |
28 Jun 2024 17:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MARRIOTT TINA | President and COO | 27 Jun 2024 | Sale | 6,000 | 7.215 | 43,290 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 3,195 | 13.1845 | 42,124 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)